Biodesix Inc.
BDSX | NASDAQ
$27.97
-$0.46 (-1.62%)
Sep 22, 2026, 11:55 AM ET · Market open
Market Data
Market Cap $231.43M
Enterprise Value $273.23M
Beta 0.59
Average Volume 89.84K
Shares Outstanding (Diluted) 10.3M
Shares Change YoY 40.41%
Institutional Ownership 37.44%
Exchange NASDAQ
ISIN US09075X2071
Price Performance
Price Change 1M 7.5%
Price Change 3M 48.4%
Price Change 6M 87.7%
Price Change YTD 340.1%
Price Change 1Y 297.6%
Price Change 3Y -3.3%
Price Change 5Y -83.5%
1M CAGR (ann.) 21.0%
1Y CAGR (ann.) 322.4%
5Y CAGR (ann.) -31.7%
All-Time CAGR -31.1%
Valuation
PE Ratio -8.97
Forward PE N/A
PEG Ratio -0.14
Forward PEG 0.24
PS Ratio 2.25
Forward PS 1.70
PB Ratio 25.31
P/FCF Ratio -7.55
P/Adj. FCF Ratio -6.46
P/OCF Ratio -14.73
EV/Sales 2.65
EV/EBIT -13.75
EV/EBITDA -19.13
EV/FCF -8.92
Earnings Yield -11.2%
FCF Yield -13.2%
Adj. FCF Yield -15.5%
Financial Health
Net Debt $16.82M
Total Debt $71.8M
Cash & Short-Term Investments $30M
Total Assets $95.33M
Current Ratio 2.85
Quick Ratio 2.85
Debt / Equity Ratio 7.85
Debt / EBITDA -5.03
Debt / FCF -2.34
OCF / Debt -0.42
Interest Coverage -2.54
Altman Z-Score -5.17
Piotroski F-Score 6
Margins & Profitability
Gross Profit Margin 82.5%
Operating Profit Margin -20.0%
EBITDA Margin -13.9%
Net Profit Margin -27.0%
FCF Margin -29.8%
Adj. FCF Margin -34.8%
SBC / Revenue 4.0%
SBC Impact (per share) -16.9%
Returns
Return on Assets -29.1%
Return on Equity -788.2%
Return on Invested Capital -25.2%
Return on Capital Employed -25.7%
Return on Tangible Assets -35.9%
Historical Growth (CAGR)
Revenue CAGR 3Y 35.2%
Revenue CAGR 5Y 6.0%
Revenue CAGR 10Y N/A
EPS CAGR 3Y 50.5%
EPS CAGR 5Y 54.1%
EPS CAGR 10Y N/A
FCF CAGR 3Y 37.2%
FCF CAGR 5Y 9.3%
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Buy
Analyst Count 8
EPS Growth Next 3Y 29.9%
Revenue Growth Next 3Y 21.4%
Earnings Date Nov 1, 2026
EPS Estimate (next Q) -$0.74
EPS Growth Est (next Q) -36.2%
Revenue Est (next Q) $27.55M
Revenue Growth Est (next Q) 26.6%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $31
Price Target Upside 9.0%
Cash Flow
Operating Cash Flow $-30M
Free Cash Flow $-30.64M
Adj. Free Cash Flow $-35.82M
FCF Per Share -$1.98
OCF Per Share -$1.93
OCF/S Ratio -19.3%
Income Statement
Revenue $102.94M
Gross Profit $84.93M
Operating Income $-20.59M
EBITDA $-14.28M
Net Income $-27.76M
EPS (Diluted) -$3.17
Revenue / Employee $308.2K
Profit / Employee $-83.12K
Employees 334
Add to Watchlist
Select watchlists to add or remove BDSX